Anita Zarina Bustam

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Symptom Experiences and Coping Strategies among Multi-ethnic Solid Tumor Patients Undergoing Chemotherapy in Malaysia

Nor Aziyan Yahaya, Pathmawathi Subramanian, Anita Zarina Bustam et al. · Asian Pacific Journal of Cancer Prevention · 2015 · 59 citations · Full text

Medicine, Clinical Sciences, Oncology +16

Lectin‐based electrophoretic analysis of the expression of the 35 kDa inter‐α‐trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies

Emida Mohamed, Puteri Shafinaz Abdul‐Rahman, Saeid Reza Doustjalali et al. · Electrophoresis · 2008 · 51 citations

Life Sciences, Biochemistry, Oncology +16

Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression

Saeid R Doustjalali, Rohana Yusof, Gopala Krishnan Govindasamy et al. · The Journal of Medical Investigation · 2006 · 43 citations · Full text

Medicine, Oncology, Pathology +17

Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators

F. Moradi, Ngie Min Ung, Mayeen Uddin Khandaker et al. · Physics in Medicine and Biology · 2017 · 41 citations

Medicine, Oncology, Radiation Oncology +17